Arca Biopharma reported $5.68M in Operating Expenses for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Amgen AMGN:US USD 4.61B 695M
Biogen BIIB:US USD 1.84B 650.7M
Brainstorm Cell Therapeutics BCLI:US USD 6.84M 750K
Bristol Myers Squibb BMY:US USD 9.46B 716M
Capricor Therapeutics CAPR:US USD 9.03M 956.93K
Cytokinetics CYTK:US USD 128.99M 4.22M
Cytrx CYTR:US USD 1.29M 7.73M
Daiichi Sankyo 4568:JP JPY 308.93B 42.65B
Gilead Sciences GILD:US USD 5.12B 917M
GlaxoSmithKline GSK:LN GBP 5.51B 1.13B
Laboratory Of America LH:US USD 3.58B 446.8M
Myriad Genetics MYGN:US USD 230M 28.6M
Otsuka Holdings 4578:JP JPY 436.4B 32.29B
Pfizer PFE:US USD 19.12B 5.9B
United Therapeutics UTHR:US USD 315.9M 114.2M